Racial and Ethnic Disparities in Hypertension: Beginning the Conversation
African Americans are significantly more likely than whites to be diagnosed with hypertension yet are significantly less likely to achieve blood pressure goals despite equal or even higher levels of treatment. Medication adherence, economic issues, patient/physician communication, and differences in antihypertensive efficacy in blacks all contribute to these disparities. It is crucial that clinicians identify opportunities for improvement in the management of hypertension in their African-American patients and integrate those opportunities into their practices.
After completing this activity, participants should be able to:
- Describe disparities in the epidemiology and management of hypertension in African Americans.
- List underlying reasons for disparities in hypertensive management in African Americans.
- Identify barriers to medication adherence in African-American patients with hypertension.
- List opportunities in their practice to overcome medication adherence barriers in minority patients with hypertension.
- Describe the components of patient-centered communication.
- Integrate patient-centered communication into their interactions with all patients, particularly minority patients.
- Apply current guidelines and algorithms for the medical management of hypertension in African Americans.
All persons who develop and/or control educational content in CME/CE activities provided by the American Heart Association will disclose to the audience all financial relationships with any commercial supporters of this activity as well as with other commercial interests whose lines of business are related to the CME/CE-certified content of this activity. In addition, presenters will disclose unlabeled/unapproved uses of drugs or devices discussed in their presentations. Such disclosures will be made in writing in course presentation materials.
PLANNING COMMITTEE/AUTHOR DISCLOSURE STATEMENTS*
Keith Ferdinand, MD (Chair)
Disclosure: Grants: Boehringer Ingelheim, Amgen Consultant/Advisory Board: Boehringer Ingelheim, Amgen, Sanofi
Shawna D. Nesbitt, MD, MS
Speaker: Daiichi Sankyo, Novartis, Advisory Board:Daiichi Sankyo, Novartis, Takeda
Myra Kleinpeter, MD, MPH
Disclosure: Speaker: Gilead Sciences, Advisory Board: Amgen
Cheryl Dennison Himmelfarb, RN, ANP, PhD, FAAN, FAHA
Kevin B. Sneed, PharmD, CRPh
*Disclosure Statements reflect faculty disclosure during content development period only
*Disclosure Statements for each event speaker will be disclosed at the beginning of the presentation
Physicians: Internists, Family Practice, Primary Care and Cardiology
Nurses: Nurses involved in the treatment of patients with or at risk for CVD
Pharmacists: Pharmacists involved in the treatment of patients with or at risk for CVD
Continuing Medical Education Accreditation - Physicians
The American Heart Association designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Continuing Medical Education Accreditation – Physician Assistants
AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society. Physician assistants may receive a maximum of 1.00 hour of Category I credit for completing this program.
Continuing Education Accreditation - Nurse Practitioners
American Academy of Nurse Practitioners (AANP) accepts AMA PRA Category 1 Credit™ from organizations accredited by the ACCME.
**AMA Credit must be claimed within 6 months of attendance. AMA credit will no longer be available to claim after the six-month credit claiming period has elapsed.
Continuing Education Accreditation - Nurses
American Heart Association is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
The maximum number of hours awarded for this CE activity is 1.00 contact hour.
**ANCC Credit must be claimed within 6 months of attendance. ANCC credit will no longer be available to claim after the six-month credit claiming period has elapsed.
Continuing Education Accreditation – Pharmacists
The American Heart Association is accredited by the Accreditation
Council for Pharmacy Education as a provider of continuing pharmacy
education. ACPE Credit:: 1.00 Contact Hour | Universal Program Number: 0256-0000-15-818-L01-P.
**ACPE Credit must be claimed within 30 days of attendance. ACPE credit will no longer be available to claim after the 30-day credit claiming period has elapsed.Steps for Successful Completion
To successfully complete this activity, learners must fully participate in the presentation.
Learners will check-in onsite and fill out an attendance verification form to return to event
coordinator upon existing presentation. In addition, learners must provide feedback that will
be used for evaluative and outcomes measurement purposes before CME/CE credit can
be claimed.RECEIVING A CERTIFICATE OF ATTENDANCE
OR CLAIMING CME/CE CREDIT
Each attendee must successfully complete the following steps:
- Attend the presentation.
- Complete the Attendance Verification Form and return to your site coordinator before leaving.
- Complete the online Evaluation Survey
- Claim your CME/CE Certificate
* At the event, the site coordinator will hand out instructions on completing the online Evaluation Survey and Claiming your CME/CE Certificate
IMPORTANT CONTACT INFORMATION
For continuing professional education/accreditation questions, please contact the AHA
National Support Center.
• Telephone: 888.242.2453
This activity is supported by an independent medical educational grant from Novartis Pharmaceuticals.